Green Tea Antioxidant Responsible For Metastatic Cancer Prevention

A PNAS study demonstrates platelet-derived growth factor D (PDGF-D) binding to PDGF receptor-beta (PDGFRβ) activates NK cells to enhance interleukin (IL)-15-mediated NK cell survival.
City of Hope research suggests that the selective introduction of PDGF signaling in NK cells by IL-15 should benefit NK cell expansion and persistence and/or enhance effector function in NK cell-based immunotherapies.

Inanovate hires new CEO to help drive next phase of growth and bring novel new blood testing technology for cancer into the clinic.

The clinical-stage biotech CytoImmune Therapeutics welcomes Puerto Rico native and biochemistry and molecular biology expert José Eduardo Vidal, Ph.D., to lead the cellular and virus manufacturing capabilities.

Privately held CytoImmune Therapeutics, Inc. strengthens its team by appointing cell therapy veteran Christina Coughlin, M.D., Ph.D. as CEO

The Distinguished Gentleman's Drive attracts thousands of vintage automotive enthusiasts in its first-ever global charity drive, raising $200,000 for men's mental health and prostate cancer research. DGD 2022 date is set for Sept. 26, 2021.

The world's first radiation dose imaging system now provides always-on, full patient coverage for clinical radiotherapy

Absecon Veterinary Hospital is proud to announce its sponsorship of Bark for Life, a community event for dogs and their people to help raise funds and awareness for the American Cancer Society, on Saturday, October 16, 11am - 5pm, at the Atlantic County 4-H Fairgrounds.

Price cuts make the revolutionary product widely available to lymphedema and cancer communities, among others in need

Crossing Blood-Brain Barrier and In Vivo Delivery of Negatively Charged Biomolecules into Glioblastoma Enabled by Altogen's Nanoparticle In Vivo Transfection Reagent

Webinar on Monday, July 26 at 10 am ET

"Cancer: The Integrative Perspective" is #1 on Amazon Special Interests New Releases

With an experienced Chief Financial Officer on board, the company is continuing to advance its fight against cancer.

New results from the OMICS study, the company's prospective, international, multi-center study, show Universal DX's blood test can detect colorectal advanced adenomas at 55% sensitivity and 90% specificity, which exceeds currently available non-invasive tests for colorectal cancer screening
80% of sporadic colorectal cancers arise from pre-malignant advanced adenomas, making early detection critical to saving lives

New results from the OMICS study, which will be presented at ASCO, show Universal DX's blood test can detect colorectal cancer with extraordinary accuracy (92% sensitivity/97% specificity), which exceeds currently available non-invasive tests for colorectal cancer screening. Early detection cancer screening via a liquid biopsy is not only critical to save lives, but is a vast market opportunity, ranging between $30B and $75B in the U.S. alone

Green Tea Antioxidant Binds to Protein Responsible For Spread of Cancer

Pre-Orders Available Now

wellCORNER™ partners with oncology healthcare professionals to leverage technology at the point of care to offer patient education and access to hemp-based products

California Cancer Associates for Research & Excellence (cCARE) experts acknowledge Breast Cancer Awareness Month by clearing up common misconceptions, hoping to save lives and help more women heal better.

Major vaccine market players include GlaxoSmithKline, Abbott Laboratories, Merck, AstraZeneca, Johnson & Johnson and Pfizer.

Congresswoman Donna Shalala to join leading scientists, developers, regulators, and policy/business decision-makers who are seeking to accelerate translation of major scientific discoveries into products that slow the aging process and onset of major chronic diseases.